COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

ROFEH CHOLIM CANCER SOCIETY INC

BROOKLYN, NY · EIN 113355081 · Form 990 · FY2024 · NTEE T50Z · Philanthropy & Grantmaking · Large ($10M-$50M)
revenue
$24.0M
expenses
$25.4M
net assets
$25.5M
employees
78
volunteers
100
program ratio
70%
mission · from form 990

THE ORGANIZATION HAS BEEN ESTABLISHED TO HELP EASE THE SUFFERING OF CANCER PATIENTS AND THEIR FAMILIES BY PROVIDING FINANCIAL SUBSIDIES, PATIENT ADVOCACY SERVICES, EMOTIONAL AND PSYCHOSOCIAL SUPPORT, ASSISTANCE IN OBTAINING MEDICAL TREATMENT, AND EDUCATION ON PREVENTION, DETECTION AND TREATMENT OF CANCER.

profile · synthesized from sources

ROFEH CHOLIM CANCER SOCIETY INC is a Brooklyn-based nonprofit that supports cancer patients and their families through financial subsidies, medical referral guidance, and advocacy. The organization helps patients navigate treatment options, access care, and overcome insurance denials. It operates nationally, focusing on psychosocial support and financial assistance for those facing economic hardship due to cancer.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $2.47M
    THE MEDICAL REFERRAL AND SUPPORT TEAM AT RCCS (ROFEH CHOLIM CANCER SOCIETY) UTILIZES ITS EXTENSIVE KNOWLEDGE TO GUIDE PATIENTS THROUGH THE MAZE OF CANCER CARE OPTIONS AND HELPS THEM EXPLORE THE MOST APPROPRIATE PHYSICIANS AND TREATMENTS FOR THEIR INDIVIDUAL DIAGNOSIS. NEWLY DIAGNOSED PATIENTS, OFTEN CONFUSED AND AFRAID, KNOW THEY CAN DEPEND ON RCCS FOR COMPASSIONATE SUPPORT AND KNOWLEDGEABLE GUIDANCE. WITH THE ASSISTANCE OF RCCS' BROAD NETWORK OF ADVISORY MEDICAL PRACTITIONERS, RCCS REPRESENTATIVES PROVIDE CANCER SUFFERERS WITH VITAL INFORMATION, ENABLING THEM TO MAKE INFORMED DECISIONS ABOUT THEIR MEDICAL CARE AS THEY NAVIGATE THEIR JOURNEY TOWARDS HEALTH.
  2. #2 $1.59M
    RCCS MAINTAINS AND ADMINISTERS A "MEDICAL SUBSIDY FUND" FOR PATIENTS AND THEIR FAMILIES WHO ARE IN DIRE FINANCIAL CONSTRAINT AS A RESULT OF CANCER AND/OR RELATED ILLNESS.
named programs · 4 · from sources

What they call their work

Insurance Advocacy Program
Advocates for patients whose life-saving treatments have been denied by insurance providers, helping secure coverage and reduce out-of-pocket expenses.
Medical Referral Fund
Supports the operations of the medical referral program, enabling patient navigation and access to specialized care.
Medical Referral and Support
Guides newly diagnosed cancer patients through treatment options and connects them with appropriate physicians using a network of medical advisors.
Medical Subsidy Fund
Provides financial assistance to cancer patients and families facing economic hardship due to illness and treatment costs.
activities · 1 group

What they do

  • Cancer Patient Financial and Practical Support 3 activities
    • Financial assistance for cancer patients through Medical Subsidy Fund
      Operates a Medical Subsidy Fund that provides financial aid to cancer patients and their families facing severe financial hardship due to illness.
    • Funding and advocacy support for denied insurance claims
      Provides funding and advocacy assistance to cancer patients whose insurance claims have been denied, helping secure access to life-saving treatments and reduce out-of-pocket costs.
    • Medical referral and support services for cancer patients
      Provides knowledgeable counseling and access to a network of advisory medical practitioners to guide cancer patients in selecting appropriate physicians and treatments.
financials · form 990 · fy2024
revenue
Total revenue$23.96M
Contributions & grants$29.08M121%
Program service revenue$00%
Investment income$486K2%
Other revenue$-5.60M
expenses
Total expenses$25.45M
Program expenses70%
Admin / overhead10%
Fundraising20%
Salaries & benefits$8.21M
Grants paid out$11.81M
Largest expense lineCompensation
balance sheet
Total assets$26.64M
Cash$5.43M
Investments$10.65M
Liabilities$1.14M
Net assets$25.50M
Liquid reserves7.6 mo
5 years on record · 2020–2024 · YoY revenue -12.0%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 8
NameTitleHours/wkCompensation
ZISHE LOWY PROGRAM DIRECTOR 40 $415K
YISROEL M MERKIN REGIONAL DIRECTOR 40 $319K
AARON STEIER NATIONAL DIRECTOR OF DEVELOPMENT 40 $300K
SHAYE WERCBERGER CHIEF SERVICES OFFICER 40 $280K
SAMUEL WERCBERGER MANAGING DIRECTOR 40 $186K
YOEL MARKOWITZ MEDICAL REFERRAL COORDINATOR 40 $177K
DANIEL HADAR DEVELOPMENT COORDINATOR 40 $171K
ELIEZER EIZIKOVITS MEDICAL CARE COORDINATOR 40 $168K
board members · 17
  • BENJAMIN BERGER CPA — BOARD MEMBER
  • BENZION WERTZBERGER — TREASURER
  • CHAIM KURZ — BOARD MEMBER
  • DR SOLOMON BLISKO — BOARD MEMBER
  • ELI KOHN — EXECUTIVE VICE PRESIDENT
  • MICHAEL BIDERMAN — BOARD MEMBER
  • MORRIS BARENBAUM ESQ — BOARD MEMBER
  • MORRIS WEISER — EXECUTIVE VICE PRESIDENT
  • NACHUM SHERMAN — BOARD MEMBER
  • RABBI YOSEF C GOLDING — BOARD MEMBER
  • SHEA ITZKOWITZ — BOARD MEMBER
  • SOL WEISS — BOARD MEMBER
  • STEPHEN GREENBERG — SECRETARY
  • STEVEN MULLER — BOARD MEMBER
  • YOEL BERNATH — EXECUTIVE BOARD MEMBER
  • ZALMEN HOROWITZ — EXECUTIVE BOARD MEMBER
  • ZVI KOHN — PRESIDENT
relationships · 1

Who they work with

  • RCCS Advisory Medical Practitioners Partner — Network of medical professionals who provide expert guidance to support RCCS's patient referral and decision-making services.
strategies · 2

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Financial Assistance to Sustain Treatment Access
    methodology: financial_assistance_for_medical_care
    By offering direct financial subsidies, the organization enables cancer patients to continue life-saving treatments during economic hardship, because alleviating financial burden removes a critical barrier to adherence and continuity of care.
  • Patient Navigation for Informed Care Access
    methodology: patient_navigation
    By providing expert-guided navigation of cancer care options, patients make more informed treatment decisions aligned with their diagnoses, which improves access to appropriate and timely care because understanding complex medical systems increases engagement and reduces delays.